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Abstract
The genetic basis of most heritable traits is complex. Inhibitory compounds and their effects in model organisms have been
used in many studies to gain insights into the genetic architecture underlying quantitative traits. However, the differential
effect of compound concentration has not been studied in detail. In this study, we used a large segregant panel from a cross
between two genetically divergent yeast strains, BY4724 (a laboratory strain) and RM11_1a (a vineyard strain), to study the
genetic basis of variation in response to different doses of a drug. Linkage analysis revealed that the genetic architecture of
resistance to the small-molecule therapeutic drug haloperidol is highly dose-dependent. Some of the loci identified had
effects only at low doses of haloperidol, while other loci had effects primarily at higher concentrations of the drug. We show
that a major QTL affecting resistance across all concentrations of haloperidol is caused by polymorphisms in SWH1, a
homologue of human oxysterol binding protein. We identify a complex set of interactions among the alleles of the genes
SWH1, MKT1, and IRA2 that are most pronounced at a haloperidol dose of 200 mM and are only observed when the
remainder of the genome is of the RM background. Our results provide further insight into the genetic basis of drug
resistance.
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Introduction
The budding yeast Saccharomyces cerevisiae has become a
powerful model for elucidating fundamental principles and
mechanisms of complex trait genetics [1]. Many quantitative trait
loci (QTL) – and the causal genes underlying these loci – have
been identified for diverse biological processes, including gene
expression [2–4], high-temperature growth [5–8], DNA damage
repair [9], sporulation efficiency [10–12], and drug sensitivity
[7,13,14]. In studies of chemical resistance traits, compound
concentrations with the highest heritability are typically selected
for further analysis [15]. However, the extent to which the genetic
architecture underlying the response to a drug is specific to the
drug dose is a major open question.
Following initial observations of complex and dose-dependent
inheritance patterns of the response to the small molecule
haloperidol, we set out to investigate the genetic basis of
haloperidol resistance as a function of dose. Haloperidol is a
psychoactive drug that binds to dopamine and serotonin receptors
in humans [16], and is widely used for treating schizophrenia. In
Saccharomyces cerevisiae (which does not contain the pharmaco-
logically relevant haloperidol targets), haloperidol exerts effects on
vesicle transport and amino acid metabolism [17], demonstrating
perturbations of fundamental cellular physiology upon exposure to
the drug. Haloperidol, a cationic amphiphilic drug, has been
shown at concentrations of 10–200 mM to cause defects in
phospholipid metabolism/transport [18,19] and trigger autophagy
upon accumulation [20] in yeast, and to result in degradation of
membranes [21] in vitro. Haloperidol was also found to inhibit
both sterol D8,7 isomerase (Erg2) and C-14 reductase (Erg24)
activities in yeast [22,23]. An early biochemical study showed that
haloperidol binds to Erg2 in yeast, and causes decreased ergosterol
levels [23]. Erg2 functions in the ergosterol biosynthesis pathway,
suggesting haloperidol’s interference with sterol metabolism and
trafficking.
Here, we used a large panel of 1008 segregants from a cross
between a laboratory strain BY4724 (hereafter referred to as BY)
and a vineyard strain RM11-1a (hereafter RM) to study yeast
growth in haloperidol. We identified a total of nine genomic loci
associated with resistance to haloperidol with different dose-
specificity. We further identified SWH1 as a major gene
contributing to resistance to haloperidol at all concentrations,
and showed that variants within its oxysterol binding protein
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(OBP)-like domain are responsible for resistance. We also showed
that variants in MKT1 and IRA2 underlie loci that have effects
predominantly at high haloperidol concentrations, and found
complex, background-dependent genetic interactions among the
allelic states of SWH1, MKT1, and IRA2. This study sheds light
on the contribution of QTL-dosage interaction to chemical
resistance in yeast, and the complexity of the underlying sources
of variation in quantitative traits.
Results
Haloperidol induces pH dependent sensitivity and
vacuole defects
To assess the biological effects of haloperidol in S. cerevisiae, we
examined susceptibility of the laboratory strain BY carrying gene
deletions erg2D, erg24D, or erg4D to haloperidol in rich medium
(Fig. 1A). Erg2, Erg24, and Erg4 make up three important steps in
the ergosterol biosynthesis pathway in yeast [24]. BY erg2D and
BY erg24D strains had growth defects in rich medium, but neither
was completely resistant to haloperidol. Erg4 catalyzes the final
step in the ergosterol biosynthesis pathway, and it has been shown
that erg4D mutants lack detectable levels of ergosterol [25].
Deleting ERG4 did not eliminate the sensitivity to haloperidol
(Fig. 1A); thus, haloperidol has biological effects other than those
on the ergosterol pathway [17].
Similar to previous observations with other cationic amphiphilic
drugs [18,20], we found sensitivity to haloperidol to be pH
dependent (Fig. 1A). Acidic pH ( = 4.3) [26] completely rescued
growth in the presence of 150 mM haloperidol (Fig. 1A). pH
related phenotypes are often indicative of vacuole-related defects
[27]. Staining of the vacuole and vacuolar membrane of
haloperidol-treated cells showed that vacuoles were intact
(Fig. 1B). Measuring acidity with fluorescent dye quinacrine
(which accumulates in acidic compartments) revealed decreased
vacuolar acidity upon longer exposure to haloperidol (Fig. 1B).
Quinacrine efficiently labeled the cytoplasm in the presence of
haloperidol, suggesting that proton-pumping mechanisms are
impaired (Fig. 1B).
Haloperidol resistance differs between strains and shows
transgressive segregation
We compared growth of BY and RM in the presence of
different concentrations of haloperidol (0–240 mM). Although RM
has higher baseline growth in the absence of haloperidol, it is more
sensitive to haloperidol at concentrations ranging from 40 to
160 mM (Fig. 2A).
We also tested segregants from a cross between BY and RM and
found that resistance to haloperidol showed transgressive segrega-
tion, with some progeny exhibiting phenotypes more extreme than
either parent (Fig. 2B). For instance, haloperidol concentration of
200 mM completely inhibited the growth of both parental strains
at 48 hours, but ,8.5% of segregants were able to grow. A formal
statistical test for transgressive segregation [28] showed that it was
significant at all measured concentrations of haloperidol between
40 mM and 200 mM (p,0.0001 in all cases; see Methods for
details).
Loci underlying haloperidol resistance have dose-
dependent effects
We sought to further understand the genetics underlying
growth in the presence of haloperidol through QTL mapping.
We carried out linkage analysis in a panel of 1008 BY-RM
segregants [15] for growth at five different concentrations of
haloperidol (40, 80, 120, 160, 200 mM) and identified nine
distinct significant QTL (Fig. 3A). At the major locus on the right
arm of chromosome I, the allele from RM (the sensitive parent)
promoted growth in the presence of haloperidol, consistent with
our observation of transgressive segregation (Fig. 2B). RM alleles
at loci on chromosomes V, XII and XV also confer greater
resistance, while BY alleles confer higher resistance at the
remaining five loci (Fig. 3).
Some of the loci were detected only at certain doses of
haloperidol, and the effect sizes of most loci were dose-dependent
(Fig. 3). For instance, the loci on chromosomes VII, XII, and XIII
were only detected at the two lower doses, while the effects of loci
on chromosomes XIV and XV primarily manifested at the higher
doses (Fig. 3B). Most loci had undetectable or weak effects at
200 mM, because few segregants grew at this dose.
We quantified the amount of variation explained by these nine
loci by fitting a linear model with additive QTL. This model
explained between 35.9% and 54.7% of the total phenotypic
variance at concentrations 40–160 mM (S1 Table). The locus on
chromosome I (right arm) alone explained 21.4%, 26.7%, 21.4%,
11.6% of the variance at these four doses, respectively.
Polymorphisms in the OBP domain of SWH1 underlie
major QTL on chromosome I
The major QTL on the right arm of chromosome I had
significant additive effects at all concentrations of haloperidol. The
confidence interval of this peak contained the gene SWH1 (also
known as OSH1), which encodes a yeast homologue of the
mammalian oxysterol-binding protein (OSBP) [29]. OSBPs are a
family of proteins with the ability to bind oxysterols [30,31], which
are oxidized derivatives of sterols in the cell.
We sequenced the coding region of the BY and RM alleles of
SWH1 and identified 13 synonymous single nucleotide polymor-
phisms (SNPs), 9 non-synonymous SNPs, and a 6 base pair indel
between the two alleles (S2 Table, Fig. 4E). According to Pfam
alignments with the amino acid sequence of Osh4 (which recently
had its crystal structure solved [32]), Swh1 contains ankyrin
repeats, a pleckstrin-homology-protein-like domain (PH), and an
oxysterol-binding-protein-like domain (OBP) at the C-terminus
[29]. Three of the non-synonymous SNPs between BY and RM
are located in the OBP domain, five are in the linker region
between the PH domain and OBP domain, and one is in the PH
domain (Fig. 4E).
Author Summary
Variation in response to a drug can be determined by
many factors. In the model organism baker’s yeast, many
studies of chemical resistance traits have uncovered a
complex genetic basis of such resistance. However, an in-
depth study of how drug dose alters the effects of
underlying genetic factors is lacking. Here, we employed
linkage analysis to map the specific genetic loci underlying
response to haloperidol, a small molecule therapeutic
drug, using a large panel of segregants from a cross
between two genetically divergent yeast strains BY (a
laboratory strain) and RM (a vineyard strain). We found that
loci associated with haloperidol resistance are dose-
dependent. We also showed that variants in the oxy-
sterol-binding-protein-like domain of the gene SWH1
underlie the major locus detected at all doses of
haloperidol. Genetic interactions among genes SWH1,
MKT1, and IRA2 in the RM background contribute to the
differential response at high concentrations of haloperidol.
Genetic Basis of Haloperidol Resistance in Yeast
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To test whether SWH1 allelic variation caused differences in
growth at different haloperidol concentrations, we conducted a
reciprocal hemizygosity analysis [5]. The BY/RM hybrids carrying
either only the BY or only the RM allele of SWH1 grew differently
in the presence of haloperidol, demonstrating that SWH1
contributes to the variable response (Fig. 4A). Specifically, the
hybrid carrying only the RM allele of SWH1 (swh1BYD/SWH1RM)
showed a higher growth rate compared to the hybrid carrying only
the BY allele (SWH1BY/swh1RMD). Thus, SWH1RM is the resistant
allele relative to SWH1BY, confirming the QTL results.
We found that deletion of SWH1 in both BY and RM haploid
backgrounds conferred higher growth rates across the response
range to haloperidol (Fig. 4B). This illustrates that SWH1 loss of
function leads to greater haloperidol resistance. To gain some
insight into the relative function of the BY and RM alleles of
SWH1, we examined the growth rates of the BY/RM hybrid
carrying none, either, or both BY and RM copies of SWH1
(Fig. 4A). With the BY allele of SWH1 intact in the hybrid, little
difference in growth rate was observed with or without the RM
allele, indicating that a single copy of the BY allele of SWH1 is
sufficient for function. Next, comparing the growth rates of the
SWH1 hemizygotes (swh1BYD/SWH1RM or SWH1BY/swh1RMD)
relative to the deletion (swh1BY D/swh1RM D), growth of swh1BYD/
SWH1RM was more similar to swh1BY D/swh1RM D (Fig. 4A).
These results demonstrate that the RM allele of SWH1 is the less
functional of the two. However, the RM allele is not a complete
loss-of-function, as deleting the RM allele of SWH1 still increased
haloperidol resistance (Fig. 4B).
Figure 1. Haloperidol induces pH dependent sensitivity and other biological effects in yeast. (A) Growth at different pH values and
haloperidol concentrations. pH 4.3: YPD at pH value 4.3; pH 7.0: YPD at pH value 7.0. Saturated cultures in liquid YPD were serially diluted 1:10 before
pinning onto agar plates. Plates were incubated at 30uC for 24–48 hr. (B) Haloperidol causes vacuole acidification related impairment. Treated versus
untreated cells were stained (see Methods) with FM4-64 (stains vacuole membrane), carboxy-DCFDA (diffuses into vacuole) after 2 hours of
haloperidol exposure, and quinacrine (accumulates in acidic compartments) after 6 hours of treatment with haloperidol at 150 mM.
doi:10.1371/journal.pgen.1004894.g001
Genetic Basis of Haloperidol Resistance in Yeast
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Analysis in the BY and RM haploids and their hybrid illustrated
that reducing SWH1 function leads to haloperidol resistance. To
explicitly test the effect of SWH1 polymorphisms on haloperidol
resistance, we swapped the SWH1 coding region in both BY and
RM (replacing the coding region with the copy from the other
strain). Introducing the functional BY allele into the RM
background slightly reduced resistance to haloperidol, whereas
having the RM allele of SWH1 in BY increased resistance. The
results from allele replacements in BY and RM haploids
demonstrated that SWH1 affects resistance to haloperidol in both
genetic backgrounds (Fig. 4C).
To gain further insight into the mechanism of resistance to
haloperidol, we looked more specifically at the polymorphisms
between BY and RM in the SWH1 gene. Among all 22 SNPs
residing in the coding region of SWH1, three of the non-
synonymous SNPs between BY and RM (D1020G, S1085L, and
I1098V) are located in the OBP domain (Fig. 4E, S2 Table). We
replaced the OBP domain of SWH1 in BY with the counterpart
from RM (hereafter BY SWH1OBP-RM) and tested resistance to
haloperidol between the replacement strains (Fig. 4D). BY
SWH1OBP-RM fully recapitulated the increased resistance to
haloperidol achieved by replacing the entire coding region of
SWH1 in BY with the RM allele. According to structure-based
alignments of Swh1 with the crystal structure of full length Osh4 in
yeast [32], D1020G lies within b-sheets (b14 - b15) that form a
hydrophobic tunnel, which can bind one sterol molecule [32].
Therefore, we speculate that D1020G in RM may result in an
altered structural form of the binding pocket and reduce Swh1
activity.
Polymorphisms in IRA2 and MKT1 contribute to
haloperidol resistance
Among the loci identified for haloperidol resistance, those on
chromosomes XIV and XV became the major QTL at higher
doses of the drug. IRA2, a gene previously identified to contain
variants underlying differences in gene expression and metabolite
levels [33,34], resides within the locus on chromosome XV. IRA2
encodes a GTPase activating protein that inhibits RAS, which
mediates cellular responses in nutrient limiting conditions via the
Ras/PKA pathway [35–37]. Analyzing allele replacement strains
for IRA2 [34], we saw that in both parental backgrounds, the
allelic state of IRA2 influenced resistance to haloperidol. The
IRA2RM allele in both BY and RM genetic backgrounds was more
resistant to the drug (Fig. 5A).
The locus on chromosome XIV is a QTL hotspot identified in
many chemical stresses, and as a QTL for growth in rich medium
[14,15,38]. It contains the gene MKT1, which encodes a protein
member of a complex involved in HO regulation [39]. A
laboratory strain allele of MKT1 has been shown to influence
gene expression [34], DNA replication stress [40] and mitochon-
drial genome stability [41]. Using BY and RM allele replacement
strains from [41], we confirmed MKT1 as the gene underlying the
chromosome XIV locus (Fig. 5B). We further found that MKT1
only had an effect in the RM background: replacing MKT1RM
Figure 2. Haloperidol resistance differs between BY and RM, and shows transgressive segregation. (A) Response of BY and RM to
haloperidol. Saturated cultures were spotted onto YPD agar plates supplemented with 0–240 mM haloperidol, incubated at 30uC for ,72 hr. Each
strain was replicated 48 times. Mean of colony radius 61 s.d. are plotted. (B) Haloperidol resistance shows transgressive segregation among progeny
from a cross between BY and RM. Cells were grown as in (A), but for 48 hours. 48 replicates of each parent (BY, RM) and 48 random segregants are
shown.
doi:10.1371/journal.pgen.1004894.g002
Genetic Basis of Haloperidol Resistance in Yeast
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withMKT1BY led to near complete resistance, while the reciprocal
allele swap had little effect on BY (Fig. 5B). The observation that
the BY allele of MKT1 led to greater growth in haloperidol is the
opposite of what has been seen for growth in other conditions in
previous complex trait studies, which found the MKT1BY allele to
be deleterious for growth in the absence of functional mitochon-
dria and in the presence of the drug 4-NQO [9,41].
Complex genetic interactions among haloperidol
resistance loci
To quantify the amount of phenotypic variance explained by
genetic variation, we calculated broad- and narrow-sense herita-
bility [15] at the five concentrations of haloperidol (Table 1).
Narrow-sense heritability ranged from 0.56 to 0.71 at doses from
40–160 mM and decreased dramatically at 200 mM. Broad-sense
heritability was consistently high (.,75%) at all doses.
Differences between broad- and narrow-sense heritability
suggest that non-additive interactions contribute to phenotypic
variance [15]. We tested for statistical interactions between
additive QTL detected in at least one haloperidol concentration,
and found 9, 10, 3, 5 and 5 significant pair-wise QTL interactions
(out of 36 possible locus pairs) at the five doses (Bonferroni-
corrected p,0.005, S1 Table, S3 Table). Incorporating the
corresponding significant two-way QTL interactions in the QTL
model at each dose explained an additional 11.0%, 6.6%, 1.7%,
7.8%, and 7.2% of phenotypic variance at 40 mM, 80 mM,
120 mM, 160 mM, and 200 mM haloperidol, respectively (S3
Table). At 40 mM, the additional variance explained accounted
for most of the difference between broad- and narrow-sense
heritability (14.6%), and at 80 mM half of this difference (12.9%)
was captured (Table 1). However, at higher doses, taking into
account two-way interactions explained little of the differences
between broad- and narrow-sense heritability (Table 1), suggesting
the presence of higher-order interactions, interactions between loci
with no detectable main effects, or other non-additive contribu-
tions to broad-sense heritability.
We detected significant pair-wise interactions at 160 mM and
200 mM among all pairs of loci on chromosomes I, XIV, and XV
that correspond to SWH1, MKT1, and IRA2 (S1 fig., S3 Table).
To further explore these interactions, we generated allele
replacement strains in both BY and RM carrying all 8
combinations of SWH1, MKT1, and IRA2 alleles (16 total
strains), and measured their growth at 200 mM haloperidol. We
tested these allelic effects and their interactions using analysis of
variance (ANOVA) and found that the pairwise interaction terms
were not significant, but all locus pairs had a significant interaction
effect with the genetic background (S4 Table). We therefore
performed ANOVA in the BY and RM background separately.
Figure 3. Loci underlying haloperidol resistance have dose-dependent effects. (A) LOD profiles for growth in the presence of increasing
doses of haloperidol. Significant loci are shown through their 1.5-LOD drop confidence intervals (blue rectangles). (B) Effect sizes of QTL underlying
haloperidol resistance as a function of dose. Effect sizes were calculated via regressing segregant phenotype on genotype (1 versus -1) at a specified
locus. Positive values represent better growth in the presence of the BY allele.
doi:10.1371/journal.pgen.1004894.g003
Genetic Basis of Haloperidol Resistance in Yeast
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The pair-wise interactions among SWH1,MKT1, and IRA2 were
all significant in the RM background, but none were significant in
the BY background (Table 2, S4, S5, and S6 Table).
These results suggest that complex interactions among the three
tested alleles (SWH1, MKT1, IRA2) and the genetic background
determine resistance to haloperidol. In the RM background, the
allelic state of SWH1 influenced the effect of MKT1. Introduction
of MKT1BY dramatically increased growth, but only in the
presence of SWH1RM (Fig. 6A). We also found interactions
between the alleles of SWH1 and IRA2 in the RM background
(Fig. 6B). IRA2RM increased growth in RM when it carried
SWH1RM and MKT1BY (Fig. 6B, left panel), but reduced growth
when it carried SWH1BY and MKT1RM (Fig. 6, right panel).
Further, the allelic state of SWH1 influenced the direction of
effect for IRA2. IRA2BY promoted growth in the presence of
the BY allele of SWH1 (Fig. 6C, left panel), but reduced
growth in the presence of the RM allele of SWH1 (Fig. 6C, right
panel).
Growth of both BY and RM in haloperidol was completely
rescued by the genotype combination MKT1BY, IRA2RM and
SWH1RM (Fig. 6). However, MKT1RM only caused sensitivity
to haloperidol in RM (Fig. 6B, right panel), even in the presence
of SWH1RM and IRA2RM. We therefore conclude that
MKT1RM, in combination with other unidentified factors in
the RM background contribute to the sensitivity of RM to
haloperidol.
Figure 4. Polymorphisms in the OBP domain of SWH1 underlie haloperidol resistance. (A) Reciprocal hemizygosity assay as well as double
deletion analysis assessing the contribution of SWH1 and its allelic state in a BY/RM hybrid background. Growth curves were spline fitted to extract
the maximum growth rates. Each experiment was performed in triplicate. The mean 61 s.d. are plotted. (B) Comparison of swh1D relative to wild
type BY and RM. Saturated cultures were spotted onto YPD agar plates supplemented with 0–240 mM haloperidol and plates were incubated at 30uC
for ,72 hr. Shown are colony size ratios obtained by normalizing colony sizes to those on YPD. Mean values 61 s.d. are plotted. (C) Allele
replacements of SWH1. Saturated cultures were spotted onto YPD agar plates supplemented with 0–240 mM haloperidol, plated were incubated at
30uC for ,48 hr. Mean colony size ratio 61 s.d. are plotted. (D) Replacing the SWH1 oxysterol binding protein like domain (OBP) in BY with the RM
counterpart (OBP-RM) recapitulates the growth rates of replacing the entire SWH1 gene with the RM allele. (E) Three nonsynonymous SNPs reside in
the oxysterol binding protein like domain (OBP) in SWH1.
doi:10.1371/journal.pgen.1004894.g004
Genetic Basis of Haloperidol Resistance in Yeast
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Discussion
The genetic architectures of chemical resistance in yeast range
from relatively simple (involving a single locus) to highly complex
(.20 loci) [9,13–15]. These studies typically tested only one dose
per compound. Here, we explored the full dose response range of
the small molecule drug haloperidol to dissect the genetic
architecture of dose-response variation in S. cerevisiae. We have
shown that loci underlying haloperidol resistance have dose-
dependent effects. We identified QTL that showed effects only at
low doses of haloperidol, and loci that showed significant effects
primarily at higher concentrations of the drug. Our study
demonstrates QTL-dosage interaction within the response range
of a single drug, and provides new insight into the complex genetic
basis of drug resistance in yeast.
We identified SWH1 (OSH1) to be the causal gene underlying
the largest effect locus in response to haloperidol. Swh1 is a protein
similar to the mammalian oxysterol-binding protein and targets to
both the Golgi and the nucleus-vacuole junction in yeast [42].
Swh1 that associates with the nucleus-vacuole junction has been
shown to act as a substrate for a degradation process, named the
piecemeal microautophagy of the nucleus (PMN) [43]. Our
observation that variants within the OBP domain of Swh1
contribute to resistance to haloperidol suggests that cellular
transport, perhaps of sterol-related molecules, is affected in the
presence of haloperidol. Cationic amphiphilic drugs have been
linked to phospholipidosis and cellular membrane damage [19],
and our identification of Swh1 suggests a potential role for
oxysterol binding proteins in these defects. We found that after
6 hours of exposure to haloperidol, yeast vacuoles were enlarged,
with the cytoplasm more acidic than the vacuoles, suggesting that
haloperidol leads to vacuole dysfunction and further linking Swh1,
vacuole functions, and haloperidol resistance. The same locus was
previously linked to growth in E6 berbamine, cobalt chloride,
copper sulphate, and neomycin [13,15]; it also overlaps with a
QTL hotspot in response to a panel of small-molecule therapeutic
drugs [13], suggesting that this locus has pleiotropic effects.
In S. cerevisiae, there are seven OSBP homologues (OSH1-7)
[44]. Previous studies of the yeast OSH genes suggested that the
seven oxysterol-binding proteins shared at least one essential role
in the cell (only deletion of all seven genes is lethal), and their
functions have significant overlap [44]. We have here provided
genetic evidence that Swh1 functions are related to resistance to
haloperidol. BY and RM display variation in both the coding and
non-coding regions of the remaining six OSH genes. These six
OSH genes do not lie in the detected QTL intervals, suggesting
that the variants within these genes may lack effects on growth in
the presence of haloperidol, either because they do not alter gene
function or because only SWH1 has an effect on growth in the
presence of haloperidol. Further studies are required to tease apart
the specific functions of the individual yeast OSH genes.
We showed that polymorphisms in MKT1 contribute to yeast
growth in the presence of high concentrations of haloperidol.
MKT1 is also a hotspot identified in eQTL [34], protein QTL
[45–47], and drug resistance studies [13] in yeast. The BY
(isogenic derivative of S288c) allele of MKT1, which is not present
Figure 5. IRA2 and MKT1 underlie resistance to haloperidol at high concentrations. (A) Comparison of colony radius ratio between BY and
RM with swapped IRA2 alleles. (B) Comparison of colony radius ratio between BY and RM with swapped MKT1 alleles. Saturated cultures were spotted
onto YPD agar plates supplemented with 0–240 mM haloperidol, plated were incubated at 30uC for ,48 hr. Mean colony size ratio 61 s.d. are
plotted.
doi:10.1371/journal.pgen.1004894.g005
Table 1. Broad (H2) and narrow (h2) sense heritability.
Haloperidol
Heritability 40 mM 80 mM 120 mM 160 mM 200 mM
H2 0.74660.039 0.83860.040 0.89760.041 0.92660.042 0.81260.040
h2 0.60060.084 0.70960.100 0.69660.096 0.55560.086 0.16660.040
H22h2 0.146 0.129 0.201 0.371 0.646
Dvar* 0.110 0.066 0.017 0.078 0.072
* Dvar shows the amount of extra variance explained by incorporating significant QTL pairwise-interactions.
doi:10.1371/journal.pgen.1004894.t001
Genetic Basis of Haloperidol Resistance in Yeast
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in other strain backgrounds, was previously shown to reduce
formation of petite colonies and compromise growth of petite cells
[41]. Lipophilic cations can pass through phospholipid mem-
branes, especially those with a large transmembrane potential,
such as the mitochondrial inner membrane. This leads to the
accumulation of these drugs in the mitochondrial matrix, inducing
mitochondrial respiration inhibition [48]. The observation that the
BY allele of MKT1 confers resistance to haloperidol suggests that
haloperidol may compromise mitochondrial integrity. Variants in
IRA2 also contribute to haloperidol resistance. The RM allele of
IRA2 inhibits the Ras/PKA pathway more strongly than the BY
allele [34]. Since PKA inhibits Msn2/Msn4, the major transcrip-
tion factors in stress response [49,50], the RM allele of IRA2 is
predicted to lead to stronger stress response, suggesting that
stronger stress response may be advantageous at high haloperidol
concentrations.
In this study, we demonstrated complex interactions among the
alleles of SWH1, MKT1, and IRA2 in the RM background at
200 mM haloperidol. Pair-wise interactions between identified loci
explained the majority of the difference between broad- and
narrow-sense heritability at 40 mM haloperidol, but not at higher
doses, suggesting higher order interactions or other non-additive
contributions. Previous studies in yeast using sporulation efficiency
as a model for complex traits [10,11] revealed linkage between
small- and large-effect QTL, as well as interactions among these
QTL. Small-effect QTL were found to depend on the allelic status
of the large-effect QTL [11], which is similar to our observation
that the effects of IRA2 and MKT1 were dependent on the allele
of SWH1 – the gene underlying the large effect QTL. Through
allele replacement analyses, we found that the interactions
between SWH1, MKT1, and IRA2 were present in the RM
background but absent in the BY background, illustrating the
value of studying genetically diverse strains.
Haloperidol and many antidepressants are cationic amphiphilic
drugs that accumulate in membranes in the absence of their
specific targets [51]. SWH1 is functionally related to sterol
trafficking and the membrane system, and underlies the QTL
detected throughout the entire dose response in haloperidol. The
identification of MKT1 and IRA2 at higher concentrations of
haloperidol suggests the effects of other cellular processes and
stress responses. Given the current knowledge on the functions of
these identified genes, the interactions between SWH1, MKT1,
and IRA2 could reflect underlying mechanisms that connect the
membrane system, sterol metabolism, and stress response. The as
yet unidentified genes underlying the remaining QTL may provide
further insight into the mechanisms of action of haloperidol.
Materials and Methods
Yeast strains, media, and chemicals
S. cerevisiae strains BY4724 and RM11-1a derived strains were
used in this study. The panel of 1008 prototrophic segregants
derived from BY (MATa) and RM (MATa hoD::HphMX4
flo8D::NatMX4 AMN1BY) was previously generated [15]. Allele
replacement strains were constructed via the Delitto Perfetto
approach using the CORE cassette [52]. This two-step process
was performed by first inserting a URA3-KanMX4 cassette from
pCORE to generate yfgD::URA3-KanMX4; then the region of
interest was amplified through high-fidelity PCR from the donor
strain, and inserted to replace the URA3-KanMX4 cassette. The
loss of the URA3-KanMX4 cassette was selected via 5-
Fluoroorotic Acid (5-FOA) counter selection of URA3 and further
selected via loss of G418 resistance. Single colonies were isolated at
each step, cassette insertions were confirmed via PCR, and allele
replacements were sequenced to verify the presence of the correct
allele. Transformations were performed by the standard lithium
acetate method. All gene sequences were obtained from the
Saccharomyces Genome Database (http://www.yeastgenome.org/
). All DNA sequencing related to strain construction and
confirmation was performed through standard dideoxy methods.
Cultures were grown in rich medium (YPD, 1% yeast extract,
2% peptone and 2% glucose). YPD liquid media and agar plates
were made as described [53]. SPO++ was used for sporulation
(http://www.genomics.princeton.edu/dunham/sporulationdissec-
tion.htm). Selection plates for strain construction were made with
YPD containing the respective drugs at standard doses. Haloper-
idol was purchased from Sigma (Sigma H1512). All drugs in this
study are dissolved in DMSO. Because BY and RM exhibit
growth defects only at DMSO concentrations .3% (v/v%),
DMSO concentrations in all experiments were kept at ,1%.
Selection agar plate construction
Drug selection agar plates were made with Nunc OmniTray
(Thermo Scientific 264728). 50 mL of YPD with drug concentra-
tions specified were poured into each tray, the trays were placed
on a flat surface to solidify in order to obtain best pinning results.
All trays contained the same final DMSO concentration. Each
experiment was performed with the same batch of YPD. Each
plate was made 6 times to allow testing 2 full replicates of the
entire segregant panel in 2 different layout configurations.
Segregants were pinned on to each agar tray in 384 well format.
Haloperidol concentrations for agar plates were selected to be 40,
80, 120, 160, and 200 mM. These concentrations capture the
Table 2. Effects of SWH1, MKT1, IRA2 genes and their interactions on growth in haloperidol (RM background, 200 mM).
Coefficients Estimate Std. Error t value Pr(.|t|)
(Intercept) 0.40242 0.02972 13.539 ,2e-16
MKT1(BY) 20.12212 0.04203 22.905 0.00396
IRA2(RM) 20.32085 0.04203 27.633 3.62e-13
SWH1(RM) 20.27910 0.04203 26.640 1.63e-10
MKT1(BY): IRA2(RM) 0.24819 0.05944 4.175 3.98e-05
MKT1(BY): SWH1(RM) 0.77430 0.05944 13.026 ,2e-16
IRA2(RM): SWH1(RM) 0.26932 0.05944 4.531 8.72e-06
MKT1(BY): IRA2(RM): SWH1(RM) 0.07578 0.08407 0.901 0.36812
doi:10.1371/journal.pgen.1004894.t002
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Figure 6. Complex genetic interactions underlie resistance to haloperidol. Growth of strains carrying all possible permutations of BY and
RM alleles of the genes MKT1, IRA2, and SWH1 in the BY and RM backgrounds grouped (A) by their IRA2 genotypes, (B) by their MKT1 genotypes, and
(C) by their SWH1 genotypes. 36 replicates of each strain were spotted onto agar supplemented with 200 mM haloperidol. Dots show the mean,
vertical bars show 1 standard deviation.
doi:10.1371/journal.pgen.1004894.g006
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growth differences between BY and RM, yet maintain enough
colony growth to allow QTL mapping.
Yeast colony growth measurement
The 1008 segregant panel are stored at 280uC in 96 well
format. They were inoculated in YPD and cultured in 384-well
plates for ,48 hours or until saturation. Two configurations were
used when converting from 96 to 384 well format, to control for
position effect and growth differences due to neighboring cells
(including blank controls). Culture plates were then fully
resuspended and pinned onto corresponding agar plates with
384 long pins using Singer RoToR. The pinned agar plates were
incubated at 30uC for 48–72 hr (as specified) and scanned with an
Epson 700 transparency scanner. TIFF images (400 dpi) were
processed for end-point colony size and effective colony radius was
used as proxy for growth [15].
QTL mapping
In order to control for both intrinsic growth rate differences and
plate position effects, end point effective colony radiuses (as
described in ‘‘Yeast colony growth measurement’’) were normal-
ized for growth on control media (YPD supplemented with same
amounts of DMSO as solvent control) through fitting a regression
for effect of growth that were in the same layout configuration on
YPD. Residuals were used for QTL mapping. Linkage was
determined by calculating LOD scores for each genotype marker
using both Haley-Knott regression and non-parametric linkage
mapping with the R/qtl package. QTL were called at a LOD
cutoff of 3. Significance was further determined by 1000
permutations of phenotypic values, and re-calculation of LOD
scores.
Growth rate quantification
Yeast cells were inoculated in rich medium in 96-well plates
(Costar 3370) and incubated at 30uC until saturation. 1% (v/v%)
of saturated culture was used in fresh medium (with or without
drug) for growth rate measurement (starting optical density OD ,
0.05). Growth curves were recorded using Synergy 2 Multi-Mode
Microplate Reader (BioTek Instruments) at 30uC with continuous
fast linear shaking (100 mL/well). OD600 were collected at 15-
minute intervals for up to 24 hours. Growth curves were spline
fitted, and the maximum fitted slope during logarithmic phase was
used as maximum growth rate. Each strain/condition was
performed in triplicate. Growth rates are shown as the mean 6
sstandard deviation. A t-test was performed between samples in
comparison to obtain p-values. All data fitting and comparison
were performed in R (http://www.r-project.org/).
Replacement analysis
Thirty-six replicates each of sixteen replacement strains (BY
background: SWH1RM,MKT1RM, IRA2RM, IRA2RM SWH1RM,
IRA2RM MKT1RM, SWH1RM MKT1RM, SWH1RM IRA2RM
MKT1RM; RM background: SWH1BY, MKT1BY, IRA2BY,
MKT1BY SWH1BY, MKT1BY IRA2BY, SWH1BY IRA2BY,
SWH1BY MKT1BY IRA2BY) and wild type progenitor BY and
RM strains were spotted onto YPD agar supplemented with 0, 40,
80, 120, 160, 200 mM haloperidol. Plates were incubated at 30uC
for ,72 hr, then scanned as described above in ‘‘Yeast colony
growth measurement’’. Colony radiuses were extracted after
image processing. The effect of replacements or replacement
combinations was compared to their otherwise isogenic progenitor
through analysis of variance (ANOVA). The analysis was
conducted in R.
Transgressive test
The test for transgression was adapted from [28]. Briefly,
segregants and parents were tabulated, and the pooled variance
was calculated. Segregants that were 2 standard deviations above
the mean of the high parent or below the mean of the low parent
were counted. The null model was constructed by pooling the
segregants and parents, and the null parents and null segregants
were randomly sampled from this pool. Significance was
determined based on resampling 10,000 times the pooled null
model.
Vacuole fluorescent staining and microscopy
Yeast cells in early to mid log-phase were divided into two
cultures of equal volume. Haloperidol (final concentration
150 mM) was added to one half, while an equal volume of DMSO
as solvent control was added to the other half. The cultures were
incubated at 30uC on a shaker for ,2 hr. Then, 26106 cells were
harvested from each culture for subsequent staining.
Quinacrine (Sigma Q3251) staining of vacuoles was performed
as described in [54]. Harvested cells were washed once in buffered
YPD (supplemented with 100 mM HEPES, pH 7.6), resuspended
in 100 mL of the same buffered medium and quinacrine at a final
concentration of 200 mM. Cell suspensions were incubated at
30uC for 10min and placed on ice for 5min. Cells were pelleted,
washed twice, resuspended with ice-old 100 mM HEPES, pH 7.6
buffer containing 2% glucose and kept on ice until imaging.
Carboxy-DCFDA (Yeast Vacuole Marker Sampler Kit, Molec-
ular Probes Y-7531) staining was performed according to kit
instructions. Briefly, harvested cells were washed and resuspended
in 50 mM sodium citrate buffer, pH 5.0, containing 2% glucose.
Carboxy-DCFDA at a final concentration of 10 mM was added to
the cell suspension followed by incubation at room temperature for
15–30min.
For FM4-64 (Molecular Probes, T-3166) staining [55], harvest-
ed cells were resuspended in 50 mL YPD with 1 mL FM4-64 stock
solution (1.6 mM in DMSO) and incubated at 30uC for 20min.
Cells were washed subsequently with 1 mL YPD at room
temperature and resuspended in 5 mL YPD to recover at 30uC
on a shaker for 90–120min. Recovered cells were washed once in
1 mL sterile ddH2O and resuspended in 200–500 mL YNB for
imaging.
All imaging was performed within 30min of staining on an
Olympus IX81 inverted fluorescence microscope [56] using a
1006 oil objective. Quinacrine and carboxy-DCFDA staining
were visualized with Chroma SP101v2 (FITC), and FM4-64 with
Chroma 49008 (mCherry TexasRed) filter sets. Images were
acquired using Slidebook 5.0 digital image acquisition software
(Intelligent Imaging Innovations) and processed using ImageJ
version 1.46r.
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